{"disease":{"id":"high-risk-percutaneous-coronary-intervention","name":"high risk percutaneous coronary intervention"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05334784","title":"Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":856,"lead_sponsor_name":"Abiomed Inc.","has_results":false},{"nct_id":"NCT07001332","title":"ELEVATE High-Risk PCI Pivotal Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":290,"lead_sponsor_name":"Magenta Medical Ltd.","has_results":false},{"nct_id":"NCT07053618","title":"Interventional Left Ventricular Assist System for PCI in CHIP Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":286,"lead_sponsor_name":"Suzhou Hengruihongyuan Medical Technology Co. LTD","has_results":false},{"nct_id":"NCT05240781","title":"Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk","phase":"NA","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"Instituto Nacional de Cardiologia Ignacio Chavez","has_results":false},{"nct_id":"NCT06373120","title":"Interventional Ventricular Assist System for PCI in CHIP Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":262,"lead_sponsor_name":"Shenzhen Core Medical Technology CO.,LTD.","has_results":false},{"nct_id":"NCT04477603","title":"Impella ECP Early Feasibility Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Abiomed Inc.","has_results":false},{"nct_id":"NCT06099548","title":"Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Magenta Medical Ltd.","has_results":false},{"nct_id":"NCT05727059","title":"Magenta Elevate™ EFS in High-Risk PCI Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Magenta Medical Ltd.","has_results":false},{"nct_id":"NCT06132568","title":"VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Boston Scientific Corporation","has_results":false},{"nct_id":"NCT06087575","title":"Early Feasibility Study of the Supira System in Patients Undergoing HRPCI","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Supira Medical","has_results":false},{"nct_id":"NCT04885816","title":"Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty","phase":"NA","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Instituto Nacional de Cardiologia Ignacio Chavez","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}